Cargando…

Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit

Detalles Bibliográficos
Autores principales: Mei, Matthew, Hamadani, Mehdi, Ahn, Kwang W., Chen, Yue, Kharfan-Dabaja, Mohamed A., Sauter, Craig, Herrera, Alex F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052914/
https://www.ncbi.nlm.nih.gov/pubmed/35112554
http://dx.doi.org/10.3324/haematol.2021.279999
_version_ 1784696884393148416
author Mei, Matthew
Hamadani, Mehdi
Ahn, Kwang W.
Chen, Yue
Kharfan-Dabaja, Mohamed A.
Sauter, Craig
Herrera, Alex F.
author_facet Mei, Matthew
Hamadani, Mehdi
Ahn, Kwang W.
Chen, Yue
Kharfan-Dabaja, Mohamed A.
Sauter, Craig
Herrera, Alex F.
author_sort Mei, Matthew
collection PubMed
description
format Online
Article
Text
id pubmed-9052914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-90529142022-05-13 Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit Mei, Matthew Hamadani, Mehdi Ahn, Kwang W. Chen, Yue Kharfan-Dabaja, Mohamed A. Sauter, Craig Herrera, Alex F. Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-02-03 /pmc/articles/PMC9052914/ /pubmed/35112554 http://dx.doi.org/10.3324/haematol.2021.279999 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Mei, Matthew
Hamadani, Mehdi
Ahn, Kwang W.
Chen, Yue
Kharfan-Dabaja, Mohamed A.
Sauter, Craig
Herrera, Alex F.
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title_full Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title_fullStr Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title_full_unstemmed Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title_short Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
title_sort autologous hematopoietic cell transplantation in diffuse large b-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052914/
https://www.ncbi.nlm.nih.gov/pubmed/35112554
http://dx.doi.org/10.3324/haematol.2021.279999
work_keys_str_mv AT meimatthew autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT hamadanimehdi autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT ahnkwangw autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT chenyue autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT kharfandabajamohameda autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT sautercraig autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit
AT herreraalexf autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit